However, as the understanding of this diseaseimproves, more potential targets are known for AD therapy—differentreceptors, proteins (APP, Aβ, tau), enzymes (lipoxygenase, acetylcholinesterase,etc). The gene discussed is ACHE; the disease is Alzheimer disease.